Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Jingyi Yang, Zhao Zhang, Fengyuan Yang, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 1, pp. 1-18
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
Jingyi Yang, Xiaoyuan Lin, Na Xing, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 8, pp. 3917-3926
Closed Access | Times Cited: 66
SYNBIP: synthetic binding proteins for research, diagnosis and therapy
Xiaona Wang, Fengcheng Li, Wenqi Qiu, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D560-D570
Open Access | Times Cited: 64
Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2
Suvro Biswas, Shafi Mahmud, Mohasana Akter Mita, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 44
Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens
Federica Guarra, Giorgio Colombo
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 16, pp. 5315-5333
Open Access | Times Cited: 33
Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation
Alireza Poustforoosh, Sanaz Faramarz, Manica Negahdaripour, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 30
The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation
Kyle Swanson, Wesley Wu, Nash L. Bulaong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Data and AI-driven synthetic binding protein discovery
Yanlin Li, Zixin Duan, Zhenwen Li, et al.
Trends in Pharmacological Sciences (2025)
Closed Access | Times Cited: 1
Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study
Anish Nag, Ritesh Banerjee, Subhabrata Paul, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105552-105552
Open Access | Times Cited: 29
Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations
Shanshan Liang, Xinguo Liu, Shaolong Zhang, et al.
Physical Chemistry Chemical Physics (2021) Vol. 24, Iss. 3, pp. 1743-1759
Closed Access | Times Cited: 37
Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review
Hamid Aria, Fatemeh Mahmoodi, Hooria Seyedhosseini Ghaheh, et al.
Analytical Biochemistry (2022) Vol. 640, pp. 114546-114546
Open Access | Times Cited: 25
Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid
Seshu Vardhan, Suban K. Sahoo
Computers in Biology and Medicine (2022) Vol. 144, pp. 105367-105367
Open Access | Times Cited: 24
Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15
Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking
Arzu Mijit, Xiaona Wang, Yanlin Li, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107183-107183
Closed Access | Times Cited: 14
Generative design of therapeutics that bind and modulate protein states
Tianlai Chen, Lauren Hong, Vivian Yudistyra, et al.
Current Opinion in Biomedical Engineering (2023) Vol. 28, pp. 100496-100496
Closed Access | Times Cited: 13
Molecular insights and optimization strategies for the competitive binding of engineered ACE2 proteins: a multiple replica molecular dynamics study
Jiahao Sun, Xinguo Liu, Shaolong Zhang, et al.
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 41, pp. 28479-28496
Closed Access | Times Cited: 13
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Nehad S. El Salamouni, Jordan H. Cater, Lisanne M. Spenkelink, et al.
FEBS Open Bio (2024) Vol. 15, Iss. 2, pp. 236-253
Open Access | Times Cited: 5
Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain
Eleni Pitsillou, Julia Liang, Raymond C. Beh, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106035-106035
Open Access | Times Cited: 20
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody
Vishakha Singh, Mandar Bhutkar, Shweta Choudhary, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150746-150746
Closed Access | Times Cited: 4
SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation
Yanlin Li, Fengcheng Li, Zixin Duan, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D595-D603
Open Access | Times Cited: 4
Unlocking the potential of in silico approach in designing antibodies against SARS-CoV-2
Tasshitra R. Subramaniam, Siti Aisyah Mualif, Weng Howe Chan, et al.
Frontiers in Bioinformatics (2025) Vol. 5
Open Access
Computational electrostatic engineering of nanobodies for enhanced SARS−CoV−2 receptor binding domain recognition
Zafar Iqbal, Muhammad Asim, Umair Khan, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions
Kaicheng Tang, Zhongjie Tang, Miaomiao Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Design of nanobody targeting SARS-CoV-2 spike glycoprotein using CDR-grafting assisted by molecular simulation and machine learning
Matheus Ferraz, Wenny Camilla dos Santos Adan, Tayná Evily de Lima, et al.
PLoS Computational Biology (2025) Vol. 21, Iss. 4, pp. e1012921-e1012921
Open Access
Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (Chiloscyllium plagiosum)
Linfei Zhao, Mingliang Chen, Xiaona Wang, et al.
Marine Drugs (2022) Vol. 20, Iss. 5, pp. 307-307
Open Access | Times Cited: 17
Targeting the omicron variant of SARS-CoV-2 with phytochemicals from Saudi medicinal plants: molecular docking combined with molecular dynamics investigations
Lina Eltaib, Abdulrahim A. Alzain
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9732-9744
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top